Literature DB >> 7561924

Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy.

M Franceschi1, G Lucignani, A Del Sole, C Grana, S Bressi, F Minicucci, C Messa, M P Canevini, F Fazio.   

Abstract

Positron emission tomography with [18F]-2-fluoro-2-deoxy-D-glucose ([18F]FDG) has been used to assess the pattern of cerebral metabolism in different types of epilepsies. However, PET with [18F]FDG has never been used to evaluate drug naive patients with cryptogenic temporal lobe epilepsy, in whom the mechanism of origin and diffusion of the epileptic discharge may differ from that underlying other epilepsies. In a group of patients with cryptogenic temporal lobe epilepsy, never treated with antiepileptic drugs, evidence has been found of significant interictal glucose hypermetabolism in a bilateral neural network including the temporal lobes, thalami, basal ganglia, and cingular cortices. The metabolism in these areas and frontal lateral cortex enables the correct classification of all patients with temporal lobe epilepsy and controls by discriminant function analysis. Other cortical areas--namely, frontal basal and lateral, temporal mesial, and cerebellar cortices--had bilateral increases of glucose metabolism ranging from 10 to 15% of normal controls, although lacking stringent statistical significance. This metabolic pattern could represent a pathophysiological state of hyperactivity predisposing to epileptic discharge generation or diffusion, or else a network of inhibitory circuits activated to prevent the diffusion of the epileptic discharge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561924      PMCID: PMC486081          DOI: 10.1136/jnnp.59.4.427

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

2.  Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome.

Authors:  B E Swartz; U Tomiyasu; A V Delgado-Escueta; M Mandelkern; A Khonsari
Journal:  Epilepsia       Date:  1992 Jul-Aug       Impact factor: 5.864

3.  The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography.

Authors:  H T Chugani; J C Mazziotta; J Engel; M E Phelps
Journal:  Ann Neurol       Date:  1987-01       Impact factor: 10.422

4.  Patterns of human local cerebral glucose metabolism during epileptic seizures.

Authors:  J Engel; D E Kuhl; M E Phelps
Journal:  Science       Date:  1982-10-01       Impact factor: 47.728

5.  Interictal and postictal focal hypermetabolism on positron emission tomography.

Authors:  H T Chugani; D A Shewmon; S Khanna; M E Phelps
Journal:  Pediatr Neurol       Date:  1993 Jan-Feb       Impact factor: 3.372

6.  High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis.

Authors:  P E Valk; K D Laxer; N M Barbaro; S Knezevic; W P Dillon; T F Budinger
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

7.  Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.

Authors:  M Reivich; A Alavi; A Wolf; J Fowler; J Russell; C Arnett; R R MacGregor; C Y Shiue; H Atkins; A Anand
Journal:  J Cereb Blood Flow Metab       Date:  1985-06       Impact factor: 6.200

8.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

9.  Local cerebral metabolism during partial seizures.

Authors:  J Engel; D E Kuhl; M E Phelps; R Rausch; M Nuwer
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

10.  Interictal metabolic anatomy of mesial temporal lobe epilepsy.

Authors:  T R Henry; J C Mazziotta; J Engel
Journal:  Arch Neurol       Date:  1993-06
View more
  6 in total

1.  18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.

Authors:  Clarissa J Liew; Young-Min Lim; Robert Bonwetsch; Sadat Shamim; Susumu Sato; Patricia Reeves-Tyer; Peter Herscovitch; Irene Dustin; Anto Bagic; Giampiero Giovacchini; William H Theodore
Journal:  Epilepsia       Date:  2008-09-17       Impact factor: 5.864

2.  Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder.

Authors:  Joseph Gonzalez-Heydrich; Alice Dodds; Jane Whitney; Carlene MacMillan; Deborah Waber; Stephen V Faraone; Katrina Boyer; Christine Mrakotsky; David DeMaso; Blaise Bourgeois; Joseph Biederman
Journal:  Epilepsy Behav       Date:  2007-03-23       Impact factor: 2.937

3.  Epilepsy associated with a cerebellar arachnoid cyst: seizure control following fenestration of the cyst.

Authors:  Yee Chiung Gan; Mary B C Connolly; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2007-08-07       Impact factor: 1.475

4.  Alterations in Cortical-Subcortical Metabolism in Temporal Lobe Epilepsy With Impaired Awareness Seizures.

Authors:  Jiale Hou; Haoyue Zhu; Ling Xiao; Charlie Weige Zhao; Guang Liao; Yongxiang Tang; Li Feng
Journal:  Front Aging Neurosci       Date:  2022-03-10       Impact factor: 5.750

5.  Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging.

Authors:  Tatjana Traub-Weidinger; Otto Muzik; Lalith Kumar Shiyam Sundar; Susanne Aull-Watschinger; Thomas Beyer; Marcus Hacker; Andreas Hahn; Gregor Kasprian; Eva-Maria Klebermass; Rupert Lanzenberger; Markus Mitterhauser; Magdalena Pilz; Ivo Rausch; Lucas Rischka; Wolfgang Wadsak; Ekaterina Pataraia
Journal:  Front Neurol       Date:  2020-01-31       Impact factor: 4.003

6.  Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism.

Authors:  Lalith Kumar Shiyam Sundar; Otto Muzik; Lucas Rischka; Andreas Hahn; Rupert Lanzenberger; Marius Hienert; Eva-Maria Klebermass; Martin Bauer; Ivo Rausch; Ekaterina Pataraia; Tatjana Traub-Weidinger; Thomas Beyer
Journal:  J Nucl Med       Date:  2019-08-02       Impact factor: 10.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.